Robust Growth in Drug And Medical Device Testing Services Market Advancements Highlighted by Industry Insig... - WhaTech

688399 Stock   68.93  0.15  0.22%   
About 62% of Jiangsu Bioperfectus' investor base is looking to short. The analysis of the overall investor sentiment regarding Jiangsu Bioperfectus Technologies suggests that many traders are alarmed. The current market sentiment, together with Jiangsu Bioperfectus' historical and current headlines, can help investors time the market. In addition, many technical investors use Jiangsu Bioperfectus stock news signals to limit their universe of possible portfolio assets.
  
Robust Growth in Drug And Medical Device Testing Services Market Advancements Highlighted by Industry Insig... WhaTech

Read at news.google.com
Google News at Macroaxis
  

Jiangsu Bioperfectus Fundamental Analysis

We analyze Jiangsu Bioperfectus' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jiangsu Bioperfectus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jiangsu Bioperfectus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Jiangsu Bioperfectus is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Jiangsu Bioperfectus Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jiangsu Bioperfectus stock to make a market-neutral strategy. Peer analysis of Jiangsu Bioperfectus could also be used in its relative valuation, which is a method of valuing Jiangsu Bioperfectus by comparing valuation metrics with similar companies.

Peers

Jiangsu Bioperfectus Related Equities

601398Industrial   0.62   
0%
52.0%
601988Bank of China   0.57   
0%
48.0%
601328Bank of Communications   0.13   
0%
11.0%
601166Industrial Bank   0.11   
9.0%
0%
601658Postal Savings   0.18   
15.0%
0%
600036China Merchants   0.29   
24.0%
0%
601318Ping An   0.51   
43.0%
0%
601998China Citic   0.74   
62.0%
0%
601939China Construction   0.82   
69.0%
0%
601288Agricultural Bank   1.18   
100.0%
0%

Complementary Tools for Jiangsu Stock analysis

When running Jiangsu Bioperfectus' price analysis, check to measure Jiangsu Bioperfectus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jiangsu Bioperfectus is operating at the current time. Most of Jiangsu Bioperfectus' value examination focuses on studying past and present price action to predict the probability of Jiangsu Bioperfectus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jiangsu Bioperfectus' price. Additionally, you may evaluate how the addition of Jiangsu Bioperfectus to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories